Sarcoma Research Group
Collaborating effectively to deliver advances in sarcoma surgery and therapeutics.
Our Research
Sarcoma cancers are rare and diverse affecting a wide age range of people. Surgery is the mainstay of treatment. Alongside adjuvant radiotherapy and chemotherapy depending on the sarcoma type.
The Newcastle Sarcoma Research Group conducts translational research and worldwide collaboration. The group were the first in the world to perform fluorescence guided surgery for sarcoma resection and are developing a preclinical pipeline to optimise the technology for this.
Clinical care is delivered in Newcastle by the North of England Bone and Soft Tissue Tumour Service which receives referrals from a wide region including Cumbria, Greater Manchester, Leeds, and the Borders in Scotland.
Our aims.
Identification of sarcoma cell surface targets for diagnosis, therapeutics and surgical imaging
To change clinical practice by performing relevant translational projects
Effective collaboration across scientific disciplines
Training of future sarcoma clinician scientists
Group members.
Translational and Clinical Research Institute, Paul O'Gorman - Kenneth Rankin, Daniel Frankel, Corey Chan, Marcus Brookes.
Positron Emission Tomography Centre - George Petrides.
Centre for Synthetic Biology and Bioeconomy - Daniel Frankel.
School of Natural and Environmental Sciences - James Knight, Toni Pringle, Katie Gristwood.
Population Health Sciences Institute - Richard McNally.
Biosciences Institute - John Lunec.
Our funding.
Our vital research, receives funding from our generous providers:
Bone Cancer Research Trust, Sarcoma UK, Newcastle Healthcare Charity, JGWP Foundation Trust, Cancer Research UK, Children with Cancer UK.
You may also be interested in:
North of England Bone and Soft Tissue Tumour Service
Positron Emission Tomography Centre
Centre for Synthetic Biology and the Bioeconomy
